Sunday, March 23, 2014 12:07:09 AM
The question is, will they actually achieve such? If the science behind 485 is real and true, well, then it's only a matter of time until this thing rockets. There's no way a major drug company would not want to swipe this up and who knows what they'd pay.
If the science is murky well, it may just build slowly or stagnate. But I'm thinking that things will probably work out in its favor.
I don't think that there'll be any problem getting the patent issued. It'll just take some time. But getting a patent issued is not as important as getting the "drug" approved. Surely getting the patent issued would boost the stock even more, but when the "drug" gets approved, phew, this thing will do a Gleason (Bang, Zoom!!)
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM